Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Marie Joséphine Fontenille"'
Autor:
Claire-Sophie Davoine, Michel Fardeau, Damien Sternberg, Emmanuel Fournier, Marie-Joséphine Fontenille, Arnaud Lacour, Norma B. Romero, Elodie De Bruyckere, D. Hantai, Julien Messéant, Geoffroy Vellieux, Sophie Nicole, Tanya Stojkovic, Sylvie Sukno, Françoise Bouhour, Jeanine Koenig, S. Bauche, E. Lacène, Pascal Laforêt, Lucie Wolf, Laure Strochlic, Guy Brochier, Bruno Eymard, Aleksandra Nadaj-Pakleza, Frédéric Chevessier, Véronique Manel, Nathalie Streichenberger, Bertrand Fontaine
Publikováno v:
Journal of Neurology
Journal of Neurology, 2017, 264 (8), pp.1791-1803. ⟨10.1007/s00415-017-8569-x⟩
Journal of Neurology, Springer Verlag, 2017, 264 (8), pp.1791-1803. ⟨10.1007/s00415-017-8569-x⟩
Journal of Neurology, 2017, 264 (8), pp.1791-1803. ⟨10.1007/s00415-017-8569-x⟩
Journal of Neurology, Springer Verlag, 2017, 264 (8), pp.1791-1803. ⟨10.1007/s00415-017-8569-x⟩
International audience; Mutations in GFPT1 (glutamine-fructose-6-phosphate transaminase 1), a gene encoding an enzyme involved in glycosylation of ubiquitous proteins, cause a limb-girdle congenital myasthenic syndrome (LG-CMS) with tubular aggregate
Autor:
Aurélie, Morin, Judith, Goncalves, Sophie, Moog, Luis-Jaime, Castro-Vega, Sylvie, Job, Alexandre, Buffet, Marie-Joséphine, Fontenille, Justine, Woszczyk, Anne-Paule, Gimenez-Roqueplo, Eric, Letouzé, Judith, Favier
Publikováno v:
Cell reports. 30(13)
Loss-of-function mutations in the SDHB subunit of succinate dehydrogenase predispose patients to aggressive tumors characterized by pseudohypoxic and hypermethylator phenotypes. The mechanisms leading to DNA hypermethylation and its contribution to S
Autor:
Thibaut Vazeille, Pierre Sonveaux, Vincent F. Van Hée, Paolo E. Porporato, Tamara Copetti, Morgane Tardy, Lucie Brisson, Piotr Bański, Caroline Bouzin, Pierre Danhier, Raphaël Frédérick, Jorge Falces, Carine Michiels, Martina Sboarina, Coralie Dethier, Marie Joséphine Fontenille
Publikováno v:
Cancer Cell
Cancer Cell, Elsevier, 2016, 30 (3), pp.418-431. ⟨10.1016/j.ccell.2016.08.005⟩
Cancer Cell, Elsevier, 2016, 30 (3), pp.418-431. ⟨10.1016/j.ccell.2016.08.005⟩
Metabolic adaptability is essential for tumor progression and includes cooperation between cancer cells with different metabolic phenotypes. Optimal glucose supply to glycolytic cancer cells occurs when oxidative cancer cells use lactate preferential
Autor:
Vincent F. Van Hée, Paolo E. Porporato, Lucie Brisson, Fabien Rodriguez, Jhudit Pérez-Escuredo, Andrea Cacace, Suveera Dhup, Marie-Joséphine Fontenille, Pierre Sonveaux, Christophe De Saedeleer, Martina Sboarina, Rajesh Kumar Dadhich
Publikováno v:
Cell Cycle
Cell Cycle, Taylor & Francis, 2016, 15 (1), pp.72-83. ⟨10.1080/15384101.2015.1120930⟩
Cell Cycle, Taylor & Francis, 2016, 15 (1), pp.72-83. ⟨10.1080/15384101.2015.1120930⟩
Oxygenated cancer cells have a high metabolic plasticity as they can use glucose, glutamine and lactate as main substrates to support their bioenergetic and biosynthetic activities. Metabolic optimization requires integration. While glycolysis and gl
Autor:
Aurélie Méneret, Bertrand Fontaine, Bertrand Philibert, Diane Doummar, Sandrine Vuillaumier-Barrot, Marie-Joséphine Fontenille, Marie Vidailhet, A Roubergue, Sophie Nicole, Emmanuel Roze, Florence Riant
Publikováno v:
Movement Disorders. 28:1457-1459
Autor:
Daniel Hantaï, Sophie Nicole, Yasmin Issop, Teresinha Evangelista, Marie-Joséphine Fontenille, Angela Abicht, Helen Griffin, Emmanuel Fournier, Damien Sternberg, Marina Dusl, A. Barois, Elodie De Bruyckere, Christine Ioos, Bruno Eymard, Amina Chaouch, Erik Stålberg, Dan Cox, Guy Brochier, S. Bauche, Hanns Lochmüller, Steven H. Laval, S. Løseth, Marijke Van Ghelue, Juliane S. Müller, T. Torbergsen, Morten Andreas Horn
Publikováno v:
Brain-A Journal of Neurology
Brain-A Journal of Neurology, 2014, 137 (9), pp.2429-2443. ⟨10.1093/brain/awu160⟩
Brain-A Journal of Neurology, 2014, 137 (9), pp.2429-2443. ⟨10.1093/brain/awu160⟩
International audience; Congenital myasthenic syndromes are a clinically and genetically heterogeneous group of rare diseases resulting from impaired neuromuscular transmission. Their clinical hallmark is fatigable muscle weakness associated with a d